Ann: Trading Halt-RAP.AX, page-108

Hi @user23 yes, that might have been me. The WHO algorithm to classify pneumonia in children has 77-81% sensitivity and 77-80% specificity when combined with clinical and radiological examinations. However, in the absence of these additional tests the algorithm only has 16-47% specificity (ie. a better than 50% chance of obtaining a false positive). I'm not sure what the WHO algorithm results are for adults, but I assume they would be similar, so I think +80% is what the market is expecting as a starting point and eventually +90% with more data & development. So +80% is good for share price, +90% is awesome. Cheers.